Gary Désir

Associate Program Director · Yale-New Haven Hospital

Credentials: · · · · ·

History

Yale-New Haven Hospital
Present
Internal Medicine at Yale School of Medicine and Yale New Haven Hospital Department · Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital
Present
Yale Institute for Global Health
Present

Development of a Novel Renalase Agonist for the Treatment of Acute Pancreatitis
National Institute of Diabetes and Digestive and Kidney Diseases · R44
PI · $4M · Bessor Pharma, Llc
2016–2028
New Target and New Therapy for Severe Covid-19 and Viral Hyperinflammation Damage: Renalase and Renalase Agonists
National Institute of Allergy and Infectious Diseases · R43
PI · $596.9K · Bessor Pharma, Llc
2023–2025
Novel Target, New Therapy: Anti- Renalase Antibody for Tumors Resistant to PD-1Inhibitors
National Cancer Institute · R44
PI · $2M · Bessor Pharma, Llc
2018–2024
Renalase Inhibition for Treatment of Unresectable Melanoma
National Cancer Institute · R01
PI · $2.4M · Yale University
2017–2023